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Preliminary findings on the experimental transmission of chronic wasting disease
agent of mule deer to cattle
Amir N. Hamir, Randall C. Cutlip, Janice M. Miller, Elizabeth S. Williams, Mick J. Stack,
Michael W. Miller, Katherine I. O’Rourke, Melanie J. Chaplin
Abstract. To determine the transmissibility of chronic wasting disease (CWD) to cattle and to provide
information about clinical course, lesions, and suitability of currently used diagnostic procedures for detection
of CWD in cattle, 13 calves were inoculated intracerebrally with brain suspension from mule deer naturally
affected with CWD. Between 24 and 27 months postinoculation, 3 animals became recumbent and were eu-
thanized. Gross necropsies revealed emaciation in 2 animals and a large pulmonary abscess in the third. Brains
were examined for protease-resistant prion protein (PrPres) by immunohistochemistry and Western blotting and
for scrapie-associated fibrils (SAFs) by negative-stain electron microscopy. Microscopic lesions in the brain
were subtle in 2 animals and absent in the third case. However, all 3 animals were positive for PrPres by
immunohistochemistry and Western blot, and SAFs were detected in 2 of the animals. An uninoculated control
animal euthanized during the same period did not have PrPres in its brain. These are preliminary observations
from a currently in-progress experiment. Three years after the CWD challenge, the 10 remaining inoculated
cattle are alive and apparently healthy. These preliminary findings demonstrate that diagnostic techniques cur-
rently used for bovine spongiform encephalopathy (BSE) surveillance would also detect CWD in cattle should
it occur naturally.
Since about 1967, a scrapie-like transmissible spongiform
encephalopathy (TSE), chronic wasting disease (CWD), has
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been identified in captive and free-ranging cervids in Colo-
rado and Wyoming.15,17–20 Chronic wasting disease has been
documented in mule deer (Odocoileus hemionus hemionus),
black-tailed deer (Odocoileus hemionus columbianus),
white-tailed deer (Odocoileus virginianus), and Rocky
Mountain elk (Cervus elaphus nelsoni).9,15,17–20 The disease
has been experimentally transmitted by intracerebral inocu-
lation of brain from mule deer into a variety of wild and
laboratory animal species.19 Except for intracerebral trans-
mission of CWD to one goat,19 CWD has not been trans-
mitted to other domestic animals.
The primary objectives of this study were to determine if
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the CWD agent could be transmitted to cattle and to provide
information about clinical course, lesions, and suitability of
currently used TSE diagnostic procedures for detection of
CWD in cattle.
Sixteen 4–6-month-old calves of mixed breed (primarily
red and black Angus) were purchased from a herd of cattle
outside the CWD endemic area and were assigned to inoc-
ulated (n 5 13) and control (n 5 3) groups. Inoculated calves
were housed in a Biosafety Level 2 isolation barn (2 animals
per pen) at the National Animal Disease Center, Ames, Iowa.
They were fed pelleted growth and maintenance rations that
contained no ruminant protein, and clean water was available
ad libitum. Control calves were housed together in an open
shed and fed pelleted growth ration and alfalfa hay. Person-
nel wore protective clothing while in the isolation facility
and showered when leaving the facility.
The inoculum was prepared from a pool of 28 CWD-
affected mule deer brains. The inoculum was positive for
scrapie associated fibrils (SAFs) by negative-stain electron
microscopy and for protease-resistant prion protein (PrPres)
by Western blot.14 In addition, this pool was infective for
orally inoculated mule deer.14 The inoculum was ground in
a mechanical grinder, gentamicin was added at 100 mg/ml,
and the final concentration of 10% (wt/vol) was made with
physiological buffered saline (PBS).
Calves were inoculated intracerebrally with 1 ml of the
CWD brain inoculum as described previously.4 Briefly, the
calves were sedated with xylazine, a midline incision was
made in the skin at the junction of the parietal and frontal
bones, and a 1-mm hole was drilled through the calvarium.
The inoculum was injected into the midbrain via a 22-gauge
9-cm-long needle while withdrawing the needle from the
brain. The skin incision was closed with a single suture.
Three calves (controls) were not inoculated.
Animals were euthanized with pentobarbital and a com-
plete necropsy was conducted on each of the carcasses. Rep-
resentative samples of all major organs were immersion
fixed in 10% neutral buffered formalin. For the purpose of
this report, only observations on central nervous system tis-
sue are documented. The brain was cut longitudinally, and
one half of the brain was fixed in formalin for not less than
3 weeks and the remainder of the brain was frozen. The
formalin-fixed brain was cut into 2–4-mm-wide coronal sec-
tions. Sections of various anatomic sites (10–15 sections per
animal) of cerebrum, cerebellum, brainstem (including the
obex), and spinal cord (cervical, thoracic, and lumbar) were
processed for routine histopathology, embedded in paraffin
wax, and sectioned at 5 mm. The sections were stained with
hematoxylin and eosin (HE) and by an immunohistochemi-
cal (IHC) method8 for detection of PrPres, with or without
formic acid pretreatment.1 Three different primary antibodies
were used, including a rabbit polyclonal antibody12 and 2
monoclonal antibodies, F89/160.1.5 and F99/97.6.1.10,11 The
latter 2 antibodies would recognize PrP sequences conserved
in most mammalian species in which natural TSEs have been
reported.10
For immunodetection of PrPres, a Western blot methoda
was used on frozen brain (caudal medulla).13 Briefly, the
method consisted of homogenization of tissues in a buffera
using a homogenizerb with disposable probes at 20,000 rpm
for 1 minute to give a 10% suspension. Protease treatment
was carried out with 2 U/ml proteinase K at 47 C for 45
minutes. The protease was inactivated using digestion stop.a
Suspensions were diluted 1:1 in sodium dodecyl sulphate
sample buffera heated to 96 C for 5 minutes and subjected
to electrophoresis on 12% precast gelsc at 200 V for 30 min-
utes. Each sample was processed in duplicate, and the pro-
teins were transferred to polyvinylidene difluoride (PVDF)
membranes (Millipore) at 150 V for 1 hour at 14 C in a
transfer tank equipped with plate electrodes.d At this stage,
proteins bound to the PVDF membrane were identified by
staining with 0.25% (w/v) Ponceau S dissolved in 0.25%
acetic acid. This was destained with tris buffered saline plus
0.5% Tween-20 (TBST) until the red color had disappeared.
The membranes were then incubated in PVDF blocking buf-
fera for 1 hour at room temperature to block nonspecific
protein binding sites. PrPres was detected by incubation with
monoclonal antibody (mAb) 6H4,a diluted 1:5,000 in block-
ing buffer, for 12–18 hours at 4 C. The membranes were
then washed 4 3 7 minutes with TBST and incubated with
goat antimouse IgG antibodies coupled to alkaline phospha-
tase (AP) diluted at 1:5,00 in blocking buffer. After another
4 3 7 minute wash, the PVDF membrane was allowed to
equilibrate for 5 minutes in luminescence buffera; excess
buffer was then drained, and 5 ml of a substratee was added
for 5 minutes. The PrPres was characterized by its partial
protease resistance, i.e., the N-terminal 60–70 amino acids
was cleaved while the rest of the protein remained intact.
This led to a reduction in molecular mass from about 35 to
27–30 kDa, which was visualized by developing and cap-
turing the chemoluminescent reaction using a multimager.
Computer softwared was used to scan the resultant images
from the PVDF membrane to the computer. Animals were
considered positive when the protein core of 27–30 kDa was
still present after proteinase K enzyme treatment.
Scrapie-associated fibrils (SAFs) were detected in fresh
brain (caudal medulla) using negative-stain electron micros-
copy.16 Where only formalin-fixed brain was available, a
modified SAF extraction technique was used.2
Twenty-two and 23 months after intracerebral inoculation,
2 animals (Calves 1745 and 1768; Table 1) gradually be-
come inappetent and lost weight. At about the same time,
one of these animals (Calf 1768) became apprehensive and
circled aimlessly in its pen. The other Calf 1745) became
listless but was excited by loud noises. These behavioral
changes continued with little variation until death of animals
8 and 14 weeks later. The altered behavior was subtle and
was most obvious to the animals’ daily caretaker. Both an-
imals were found recumbent (24 and 26 months postinocu-
lation; Table 1) and were euthanized. Following these 2
deaths, a control animal (Calf 1732; Table 1) was euthanized
to obtain tissues for histopathology and to test for the pres-
ence of PrPres. A third animal (Calf 1744; Table 1) developed
lameness in one leg at approximately 27 months postinoc-
ulation. Because it had overgrown hooves, its feet were
trimmed under general anesthetic. Recovery was uneventful
and the animal’s gait appeared to improve. However, a week
later, it was found recumbent and was euthanized.
At necropsy, 2 animals were emaciated (Calves 1745 and
1768; Table 1), but other gross lesions were not evident. Calf
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* IHC 5 immunohistochemistry for PrPres; SAF 5 scrapie-associated fibrils; NA 5 not applicable; WB 5 western blot (Prionics-Checka);
1 5 lesions or antigen present; 2 5 lesions or antigen absent; 1/2 5 signs/lesions equivocal; i/c 5 intracerebral.
† This animal was euthanized after acute lamenss and recumbency.
Figure 2. Brain; medulla oblongata of calf 1768. A neuron with
a single large vacuole is present in the accessory cuneate nucleus.
HE 2003.
Figure 1. Brain; medulla oblongata of animal 1768. Several hy-
pereosinophilic degenerate axons (arrows) are present near the nu-
cleus of dorsal vagus (not showing the photomicrograph). HE 2003.
1744 (Table 1), which was in a good nutritional state, had a
large (approximately 20 cm in diameter) pulmonary abscess
in one of the diaphragmatic lobes. The abscess contained
copious, thick, greenish, purulent material that was sur-
rounded by a thick, fibrous capsule. Other lesions were not
seen in this animal or in the control animal (Calf 1732; Table
1).
Results of neurohistopathological findings and the PrPres
tests are summarized in Table 1. Microscopic examination
of HE-stained brain and cervical cord sections revealed iso-
lated vacuolated neurons, a few degenerate axons and mild
astrocytosis in 2 CWD-inoculated cattle (Calves 1745 and
1768; Table 1). Axonal degeneration and vacuolated neurons
were in the medulla oblongata at the level of the obex of
animal 1768. The degenerate axons did not involve any par-
ticular nuclei but were some distance from the dorsal vagus
nucleus (Fig. 1), whereas the vacuolated neurons were in the
accessory cuneate nucleus (Fig. 2). The control animal (Calf
1732) had moderate numbers of vacuolated neurons in the
red nucleus.
The PrPres was detected by IHC in the brains of all 3
inoculated cattle. The anatomical distribution and staining
pattern was similar with all 3 antibodies, with or without
formic acid treatment of sections. The anatomical distribu-
tion of PrPres was widespread, appearing in the cervical spi-
nal cord and throughout the brain except in the cerebellar
folia. The greatest amount of staining was present in the
medulla oblongata and in the midbrain. The staining pattern
was multifocal (Fig. 3), and most of the reactivity was con-
centrated in or around astrocytes (Fig. 4). There was also
some scattered particulate or granular staining in neuropil,
and small plaques (up to 40 mm in diameter) were occasion-
ally observed (Fig. 5). Staining in neuronal cytoplasm was
uncommon, and there was no perineuronal or perivascular
staining. The PrPres was not present in tissue sections from
brain of the control animal.
The PrPres was detected by Western immunoblottng in
brain material from all 3 inoculated animals. A clear profile
of the 3 glycosylated bands (diglcosylated, monoglycosylat-
ed, and unglycosylated) could be seen, although only a weak
signal was present for animal 1744 (Fig. 6).
The SAFs were detected in formalin-fixed brain tissue ex-
tracts from animal 1744 (Fig. 7) and fresh tissue extracts
from animal 1768 but not from the other inoculated animal
or the control.
Chronic wasting disease is a transmissible spongiform en-
cephalopathy and, like all other TSEs, it is characterized by
a long incubation period, which in deer is seldom less than
18 months.19 In cervids, clinical CWD is characterized by
emaciation, changes in behavior, and excessive salivation.20
Although the latter was not observed in the 3 CWD inocu-
lates described in this study, 2 animals (Calves 1745 and
1768; Table 1) developed reduced appetite and had consid-
erable weight loss approximately 2 years after inoculation
and their carcasses were emaciated at necropsy. These ani-
mals also showed subtle behavioral changes that were more
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Figure 3. Brain; medulla oblongata of calf 1745. Multiple foci
of PrPres staining (red) are present. Stained for PrPres by IHC. 303.
Figure 4. (a) Brain; medulla oblongata of calf 1745. (b) brain;
cerebral cortex of calf 1744. The PrPres accumulations are located
predominantly in or around astrocytes. Stained for PrPres by IHC.
2003.
obvious to animal caretakers who had frequent contact with
the animals.
Morphological lesions in the current study were subtle in
the first 2 affected animals and absent in the third animal.
However, all 3 animals were positive for PrPres by IHC and
Western blot, and in 2 of the animals, SAFs were detected.
These findings indicate that some domestic cattle are sus-
ceptible to CWD by experimental intracerebral inoculation.
However, only 3 of 13 animals have died to date, and the
outcome of inoculation of the remaining cattle remains to be
determined. In a previous experiment,4 100% of cattle in-
oculated intracerebrally with the US-scrapie agent died 14–
18 months after inoculation.
It could be argued that the PrPres seen in tissue sections
was residual CWD material from the inoculum. However, if
this were true, then the PrPres would most likely have been
observed as locally extensive areas of PrPres in the midbrain
and cerebrum (site of inoculation). Instead, there was a mul-
tifocal distribution of PrPres throughout the brain (excluding
cerebellar folia) and also in the cervical spinal cords of all
3 inoculated animals.
The localization of PrPres accumulation in brains of CWD-
inoculated cattle was unusual because the primary target
seemed to be astrocytes. The PrPres accumulation in astro-
cytes has been previously reported in a study of early scrapie
pathogenesis in experimentally inoculated mice.5 It should
be noted that, because only 3 of 13 CWD-inoculated cattle
have died thus far, the astrocytic PrPres may represent an
early pathologic response to inoculation and a different IHC
pattern could emerge later in the course of disease. This
same caveat applies to the absence of clearly defined clinical
signs or characteristic TSE histologic lesions in these 3 an-
imals.
The astrocytic pattern of IHC staining CWD-inoculated
cattle was distinctly different from the PrPres distribution ob-
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Figure 5. Brain; thalamus of calf 1768. A cluster of several
small PrPres plaques. Stained for PrPres by IHC. 1253.
Figure 7. Negatively stained scrapie associated fibril (SAF) ob-
served in formalin-fixed tissue extract (caudal medulla) from calf
1744. 156,0003.
Figure 6. Western immunoblot showing distinct profile of PrPres (molecular weight 27–30 kD) in the 3 positive animals (Calves 1744,
1745, 1768). No signal is seen in calf 1732, classified as negative. A normal PrPc control (molecular weight 33—35 kD) is in the first
lane. Molecular weight marker positions are indicated on the right-hand side of the image.
served in cattle inoculated intracerebrally with brain homog-
enate from scrapie-affected sheep.4 In those animals, PrPres
was almost totally restricted to neuronal cytoplasm, a stain-
ing pattern that persisted even after second passage in cattle.3
It is intriguing that 2 such different PrPres staining patterns
are produced in cattle by intracerebral inoculation of TSE
agents, depending on the source of inoculum (scrapie or
CWD). It should be noted that both of these staining patterns
differ from the staining reactions described in animals with
naturally acquired scrapie, BSE, or CWD.6–8 In those dis-
eases, the IHC reactivity is described as a diffuse particulate
staining of gray matter neuropil, with occasional plaques
also being present in scrapie and CWD, especially in the
latter.6–8
This study involved intracerebral inoculation of CWD
agent to cattle. This is an unnatural route and as such has
little bearing on the potential for cattle to become infected
under natural conditions of exposure. It is likely that trans-
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mission of CWD to cattle by a more natural route, such as
per os as seen with scrapie in sheep, would be much more
difficult or even impossible to accomplish. Such an experi-
ment is currently in progress at the University of Wyoming,
and approximately 3 years into the study, the exposed cattle
remain healthy.
At the time of writing this article (approximately 3 years
after inoculation), the 10 remaining intracerebrally inoculat-
ed cattle are alive and apparently healthy. They will be kept
under observation for a further period of at least 4 years
before the experiment is terminated.
Although a final assessment of relative risk for CWD
transmission to cattle is not possible at this time, these pre-
liminary results show that the diagnostic tests used for BSE
surveillance in the USA would allow detection of CWD in
cattle, should it occur.
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